Clinical Trials · NCT02177773
GA-68 DOTA-TOC of Somatostatin Positive Malignancies
- Phase
- Phase 1/Phase 2
- Recruitment status
- Terminated
- Sponsor
- University of California, San Francisco
- Enrollment
- 300
- Start date
- Jun 2014
- Locations
- 1 site, United States
- Primary endpoint
- Number of Lesions as Determined by Gallium Ga 68-DOTA-TOC Positron Emission Tomography (PET) Imaging